Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Karyopharm Therapeutics
KPTI
$42.2M
| $17.1M | 0.02% |
84,818
+55,696
| +191% | +$11.1M |
|
|
SRC
977
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $17.1M | 0.02% |
490,205
-454,828
| -48% | -$16.2M |
|
|
CSGS
978
DELISTED
CSG Systems International
CSGS
| $16.9M | 0.02% |
374,227
+17,188
| +5% | +$788K |
|
|
FINL
979
DELISTED
Finish Line
FINL
| $16.9M | 0.02% |
1,251,109
+1,065,195
| +573% | +$12.3M |
|
980
American Financial Group
AFG
$12B
| $16.9M | 0.02% |
150,859
+129,538
| +608% | +$14.5M |
|
981
CytomX Therapeutics
CTMX
$717M
| $16.9M | 0.02% |
594,788
-242,627
| -29% | -$6.92M |
|
|
BZUN
982
Baozun
BZUN
$164M
| $16.9M | 0.02% |
+367,978
| New | +$14.5M |
|
983
Columbia Sportswear
COLM
$3.08B
| $16.9M | 0.02% |
220,618
+171,098
| +346% | +$12.9M |
|
984
Globus Medical
GMED
$11.3B
| $16.9M | 0.02% |
338,418
+48,022
| +17% | +$2.26M |
|
|
BAS
985
DELISTED
Basis Energy Services, Inc.
BAS
| $16.8M | 0.02% |
1,164,095
+163,202
| +16% | +$3.16M |
|
986
Open Text
OTEX
$5.95B
| $16.8M | 0.02% |
482,756
+375,966
| +352% | +$13.1M |
|
987
Vanda Pharmaceuticals
VNDA
$322M
| $16.8M | 0.02% |
996,275
-131,290
| -12% | -$2.2M |
|
988
Insperity
NSP
$1.99B
| $16.8M | 0.02% |
240,847
+106,443
| +79% | +$6.8M |
|
989
PUT
CSX Corp
CSX
$95.3B
| $16.7M | 0.02% |
+900,000
| New | +$16.8M |
|
990
Inogen
INGN
$146M
| $16.7M | 0.02% |
135,994
-135,934
| -50% | -$16.6M |
|
991
Korn Ferry
KFY
$4.35B
| $16.7M | 0.02% |
323,724
-165,215
| -34% | -$7.35M |
|
992
OSI Systems
OSIS
$3.36B
| $16.7M | 0.02% |
255,483
-170,680
| -40% | -$11.1M |
|
993
Arbor Realty Trust
ABR
$979M
| $16.6M | 0.02% |
1,887,718
+242,154
| +15% | +$2.06M |
|
|
CIT
994
DELISTED
CIT Group Inc.
CIT
| $16.6M | 0.02% |
323,288
+169,822
| +111% | +$8.92M |
|
995
Expeditors International
EXPD
$24.4B
| $16.6M | 0.02% |
262,610
+146,339
| +126% | +$9.41M |
|
|
ADAP
996
DELISTED
Adaptimmune Therapeutics
ADAP
| $16.6M | 0.02% |
1,477,641
+672,046
| +83% | +$5.88M |
|
|
PRTY
997
DELISTED
Party City Holdco Inc.
PRTY
| $16.5M | 0.02% |
1,060,473
+833,855
| +368% | +$12.6M |
|
998
Nice
NICE
$5.87B
| $16.5M | 0.02% |
175,701
+159,773
| +1,003% | +$14.9M |
|
999
Rithm Capital
RITM
$5.72B
| $16.3M | 0.02% |
993,299
-1,352,922
| -58% | -$23M |
|
1000
Sixth Street Specialty
TSLX
$1.8B
| $16.3M | 0.02% |
911,471
+277,757
| +44% | +$5.21M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.